SCHEMBL10100448

SCHEMBL10100448

Cc1ccc(S(=O)(=O)C(CC(C)C)NCC(=O)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.50
ALDH1A1 P00352 5/20 0.47
TDP1 Q9NUW8 2/20 0.47
TP53 P04637 1/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD11B1 P28845 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10100441 0.84 RECQL (0.55) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL10100459 0.82 RECQL (0.52) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL10100444 0.82 RECQL (0.47) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL15167336 0.75 CA2 (0.57) ALDH1A1TDP1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL10100452 0.75 RECQL (0.47) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL10100455 0.74 RECQL (0.46) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL5320466 0.73 ALDH1A1 (0.60) RECQLALDH1A1TDP1TP53RAB9A
SCHEMBL6348182 0.71 DPP4 (0.47) ALDH1A1TDP1MEN1KMT2ASMN1; SMN2
SCHEMBL5869355 0.71 DPP4 (0.47) ALDH1A1TDP1MEN1KMT2ASMN1; SMN2
SCHEMBL4102495 0.70 ALDH1A1 (0.57) ALDH1A1TDP1RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097750-B2 Highly enantioselective, converting aromatic and aliphatic aldehydes into optically active aryl and alkyl beta -amino acids BRANDEIS UNIVERSITY (US) 2012-01-17 US disclosed
US-20080228000-A1 Cinchona Alkaloid-Catalyzed Asymmetric Mannich Reactions BRANDEIS UNIVERSITY (US) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080228000-A1 Cinchona Alkaloid-Catalyzed Asymmetric Mannich Reactions MANBA, MAN2A1, ASNS RECQL 3818/4885ALDH1A1 600/4885TDP1 4230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.